Polymerizable compound, liquid crystal composition and liquid crystal display device
By using a combination of specific polymerizable compounds and liquid crystal compounds in the liquid crystal display device, the shortcomings of the liquid crystal display device in the prior art in terms of low voltage driving, response time and operating temperature range are solved, and good pretilt angle stability and Low temperature storage, suitable for a variety of liquid crystal display types.
Patent Information
- Application Number
- CN202011106134.3
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Priority Date
- 2020-03-04
- Filing Date
- 2020-10-14
- Publication Date
- 2024-11-08
- Estimated Expiration
- 2040-10-14
AI Technical Summary
The existing liquid crystal display devices have shortcomings in low voltage driving, high speed response time, high voltage retention rate, low rotational viscosity and wide operating temperature range, which are difficult to meet a variety of application needs.
A new polymerizable compound is provided with a chemical formula consisting of a specific ring structure and alkylene substituted groups for forming a stable pretilt angle arrangement in a liquid crystal display device, combined with other liquid crystal compounds, through photocuring processes and electric field adjustments. , realize excellent display performance of liquid crystal.
It realizes good pretilt angle stability and low-temperature storage of the liquid crystal display device, improves display performance and adaptability, and is suitable for liquid crystal display devices of VA, TN, IPS, FFS, OCB and PDLC.
Smart Images

Figure CN113354537B_ABST
Abstract
Description
[Technical field]
[0001] The present invention relates to the field of display technology, and in particular to a polymerizable compound, a liquid crystal composition and a liquid crystal display device. [Background technology]
[0002] With the widespread use of liquid crystal display devices, compounds used in liquid crystal display devices are also required to have various properties (such as low voltage drive, high speed response time, high voltage retention rate, low rotational viscosity, wide operating temperature range, etc.). Therefore, the industry is still continuing to look for novel compounds and mixtures that meet various applications.
[0003] In recent years, polymer-sustaining alignment technology (PSA) has been widely used to mass-produce liquid crystal display devices. The principle of this technology is to add one or more polymerizable compounds to the liquid crystal medium, mix them evenly and inject them into the conductive substrate of the display component. Under the irradiation of ultraviolet light of a suitable wavelength, the polymerizable compound monomers are polymerized into a polymer structure on the substrate, so that the liquid crystal forms a stable pre-tilt arrangement along the polymer structure, thereby achieving the alignment of the liquid crystal. Through the above-mentioned technology, PSA-VA, PSA-TN, PSA-IPS, PSA-FFS and PSA-OCB display devices have been widely studied. In addition, polymer-dispersed liquid crystal (PDLC) is a composite film in which anisotropic liquid crystal droplets are uniformly dispersed in a polymer. It adjusts the arrangement of the liquid crystal by changing the electric field between the upper and lower substrates to control the relationship between the refractive index of the liquid crystal and the polymer, so as to achieve an optical display effect between the foggy state and the transparent state. PDLC can be used not only in liquid crystal display devices but also in smart glass, so the industry is actively developing new compounds with better properties. [Summary of the invention]
[0004] Therefore, an object of the present invention is to provide a novel polymerizable compound.
[0005] In one embodiment of the present invention, the polymerizable compound has a chemical formula as shown in formula (I):
[0006]
[0007] in
[0008] Ring A and Ring B are each independently 1,4-cyclohexylene, 1,4-phenylene, naphthalene-2,6-diyl, indan-1,5-diyl, indan-2,5-diyl or 1,2,3,4-tetrahydronaphthalene-2,6-diyl, wherein the alkylene group is unsubstituted or at least one -CH2- is substituted by -O- or -C=C-;
[0009] Z1 and Z2 are each independently a C1-C4 straight chain alkylene, -CF2O-, -OCF2- or a single bond, wherein the alkylene is unsubstituted or at least one -CH2- is substituted by -O-, -C=C- or -C≡C-;
[0010] n and m are each 0, 1, 2, 3 or 4, and n+m=1-4; when n+m≥2, the plurality of rings A and B are the same or different from each other, and Z1 and Z2 are the same or different from each other;
[0011] R is C1~C 12 Alkyl, C1~C 12 Alkoxy, C2~C 12 alkenyl or P, wherein the alkenyl is unsubstituted or has at least one carbon hydrogen substituted with fluorine; and
[0012] P is
[0013] Another object of the present invention is to provide a liquid crystal composition comprising one or more of the above-mentioned polymerizable compounds.
[0014] Another object of the present invention is to provide a liquid crystal display device comprising the above-mentioned liquid crystal composition. [Specific implementation method]
[0015] Before describing in detail at least one embodiment of the present invention, it should be understood that the present invention is not necessarily limited to the details illustrated by the examples in the following description, such as the number of embodiments or the specific mixing ratios adopted, etc. The present invention can be implemented or realized in other embodiments or in various ways.
[0016] [Polymerizable compound]
[0017] The present invention provides a polymerizable compound that can be used for PSA-VA, PSA-TN, PSA-IPS, PSA-FFS, PSA-OCB and PDLC. A liquid crystal composition and a liquid crystal display device containing the polymerizable compound have good pre-tilt angle stability and low-temperature storage performance.
[0018] The polymerizable compound has a chemical formula as shown in formula (I):
[0019]
[0020] in
[0021] Ring A and Ring B are each independently 1,4-cyclohexylene, 1,4-phenylene, naphthalene-2,6-diyl, indan-1,5-diyl, indan-2,5-diyl or 1,2,3,4-tetrahydronaphthalene-2,6-diyl, wherein the alkylene group is unsubstituted or at least one -CH2- is substituted by -O- or -C=C-;
[0022] Z1 and Z2 are each independently a C1-C4 straight chain alkylene, -CF2O-, -OCF2- or a single bond, wherein the alkylene is unsubstituted or at least one -CH2- is substituted by -O-, -C=C- or -C≡C-;
[0023] n and m are each 0, 1, 2, 3 or 4, and n+m=1-4; when n+m≥2, the plurality of rings A and B are the same or different from each other, and Z1 and Z2 are the same or different from each other;
[0024] R is C1~C 12 Alkyl, C1~C 12 Alkoxy, C2~C 12 alkenyl or P, wherein the alkenyl is unsubstituted or has at least one carbon hydrogen substituted with fluorine; and
[0025] P is
[0026] In one embodiment of the present invention, Z1 and Z2 are each independently -OCH2-, -CH2O-, -O(CH2)3-, -(CH2)3O-, -OC2H4O-, -C=C-, -C≡C-, -CF2O-, -OCF2- or a single bond.
[0027] In one embodiment of the present invention, the ring A and the ring B are each independently 1,4-phenylene or naphthalene-2,6-diyl which is unsubstituted or has at least one hydrogen on carbon substituted by fluorine, C1-C5 straight-chain alkylene or C3-C5 branched alkylene; the Z1 and Z2 are each independently -OCH2-, -CH2O- or a single bond; n+m=1-3.
[0028] In one embodiment of the present invention, the ring A is 1,4-phenylene which is unsubstituted or has at least one hydrogen on carbon substituted by fluorine, C1-C5 straight-chain alkylene or C3-C5 branched alkylene, Z1 is a single bond, n=1-2, m=0, R is P, and the definition of P is the same as above.
[0029] In one embodiment of the present invention, the ring A and the ring B are 1,4-phenylene which is unsubstituted or has at least one hydrogen on carbon substituted by fluorine, C1-C5 straight chain alkylene or C3-C5 branched chain alkylene, Z1 and Z2 are each independently -OCH2-, -CH2O- or a single bond, n=0-3, m=0-3, n+m=3, R is P, and the definition of P is the same as above.
[0030] Specific examples of formula (I) of the present invention include formula (I-1) to formula (I-11):
[0031]
[0032]
[0033] [Liquid crystal composition]
[0034] The liquid crystal composition provided by the present invention comprises the polymerizable compound represented by the above formula (I). The liquid crystal composition of the present invention can make the display device have good pre-tilt angle stability after the photocuring process by comprising the polymerizable compound represented by the above formula (I), and the polymerizable compound has good low-temperature storage property in the liquid crystal composition.
[0035] Specifically, the polymerizable compound represented by formula (I) is based on the overall content of the liquid crystal compound as 100%, and its external addition ratio ranges from 0.01 to 10% by weight, preferably from 0.02 to 2% by weight, and more preferably from 0.05 to 1% by weight.
[0036] The liquid crystal composition provided by the present invention may further include liquid crystal compounds with other characteristics. Preferably, the liquid crystal composition further includes one or more compounds of formula (II):
[0037]
[0038] in
[0039] R 21 and R 22 are independently hydrogen, a halogen atom, a C1-C 15 Alkyl or C2~C 15 alkenyl, and wherein the C1 to C 15 Alkyl or the C2~C 15The alkenyl group is unsubstituted or at least one hydrogen atom is substituted by a halogen atom, and / or at least one -CH2- is substituted by -O-, and -O- is not directly connected to -O-;
[0040] Ring B 1 , B 2 and B 3 Each is independently 1,4-phenylene, 1,4-cyclohexylene, 2,5-benzofuranylene, 1,3-dioxane-2,5-diyl, 2,5-tetrahydropyranylene, a divalent dioxa-bicyclo[2.2.2]octane functional group, a divalent trioxa-bicyclo[2.2.2]octane functional group, tetralin-2,6-diyl or indan-2,5-diyl. wherein the 1,4-phenylene, the 1,4-cyclohexylene, the 1,3-dioxane-2,5-diyl, the 2,5-benzofuranylene, the tetralin-2,6-diyl, the indan-2,5-diyl or the 2,5-tetrahydropyranylene is unsubstituted or at least one hydrogen atom is substituted by a halogen atom or -CN, and / or at least one -CH2- is substituted by -O-, -N- or -S-, and wherein the -O-, -N- and -S-substituted atoms are not directly connected to each other;
[0041] Z 21 and Z 22 Each independently represents a single bond, C1-C4 alkylene, C2-C4 alkenylene, or C2-C4 alkynylene, wherein the C1-C4 alkylene, the C2-C4 alkenylene, or the C2-C4 alkynylene is unsubstituted or at least one hydrogen atom is substituted by a halogen atom or -CN, and / or at least one -CH2- is substituted by -O- or -S-, and -O- is not directly connected to -O- or -S-, and -S- is not directly connected to -S-; and
[0042] n 21 is 0, 1, or 2, and when n 21 When the two B 1 The groups may be the same as or different from each other.
[0043] Specifically, the ratio of the compound of formula (II) to the whole liquid crystal compound is in the range of 40 to 100 weight %, preferably 50 to 100 weight %, and more preferably 60 to 100 weight %.
[0044] Preferably, the compound of formula (II) is a compound of the following formula (II-1) or formula (II-2):
[0045]
[0046] in
[0047] R 21 and R22 are independently hydrogen, a halogen atom, a C1-C 15 Alkyl or C2~C 15 alkenyl, and wherein the C1 to C 15 Alkyl or the C2~C 15 The alkenyl group is unsubstituted or at least one hydrogen atom is substituted by a halogen atom, and / or at least one -CH2- is substituted by -O-, and -O- is not directly connected to -O-;
[0048] Ring B 1 and B 2 are each independently 1,4-phenylene, 1,4-cyclohexylene, 2,5-benzofuranylene, 1,3-dioxane-2,5-diyl, 2,5-tetrahydropyranylene, a divalent dioxa-bicyclo[2.2.2]octane functional group, a divalent trioxa-bicyclo[2.2.2]octane functional group, tetralin-2,6-diyl or indan-2,5-diyl, wherein the 1,4-phenylene, the 1,4-cyclohexylene, , the 1,3-dioxane-2,5-diyl, the 2,5-benzofuranyl, the tetralin-2,6-diyl, the indan-2,5-diyl or the 2,5-tetrahydropyranyl is unsubstituted or at least one hydrogen atom is substituted by a halogen atom or -CN, and / or at least one -CH2- is substituted by -O-, -N- or -S-, and the -O-, -N- and -S- substitution atoms are not directly connected to each other;
[0049] Z 22 are independently a single bond, C1-C4 alkylene, C2-C4 alkenylene, C2-C4 alkynylene, wherein the C1-C4 alkylene, the C2-C4 alkenylene or the C2-C4 alkynylene is unsubstituted or at least one hydrogen atom is substituted by a halogen atom or -CN, and / or at least one -CH2- is substituted by -O- or -S-, and -O- is not directly connected to -O- or -S-, and -S- is not directly connected to -S-;
[0050] n 21 is 0, 1, or 2, and when n 21 When the two B 1 The groups may be the same as or different from each other.
[0051] Specifically, the proportion of the compound of formula (II-1) in the overall liquid crystal compound is in the range of 5 to 60 weight %, preferably 10 to 50 weight %, and more preferably 15 to 40 weight %; the proportion of the compound of formula (II-2) in the overall liquid crystal compound is in the range of 20 to 90 weight %, preferably 25 to 80 weight %, and more preferably 30 to 70 weight %.
[0052] Specifically, the above-mentioned liquid crystal compounds can be exemplified as follows, including but not limited to:
[0053]
[0054] wherein n and m are each independently 1, 2, 3, 4 or 5.
[0055] More specifically, the liquid crystal compounds include but are not limited to:
[0056]
[0057]
[0058] The liquid crystal composition provided by the present invention may further include one or more other polymerizable compounds. Preferably, the other polymerizable compounds include but are not limited to compounds represented by formula (III), formula (IV) or formula (V):
[0059]
[0060]
[0061] in
[0062] K 21 , K 22 , K 23 and K 24 are each independently hydrogen or methyl;
[0063] Z 23 and Z 24 Each independently is a single bond, C1~C 15 Straight chain alkylene, C3~C 15 Branched alkylene, C2~C 15 Straight chain alkenylene or C3~C 15 branched alkenylene, wherein the C1 to C 15 Straight chain alkylene, the C3~C 15 The branched alkylene group, the C2 to C 15 Straight chain alkenylene or the C3~C 15 The branched alkenylene group is unsubstituted or at least one hydrogen atom is substituted by a halogen atom, and / or at least one -CH2- is substituted by -O-, -CO-, -COO- or -OCO-, and the -O-, -CO-, -COO- and -OCO- are not directly connected to each other;
[0064] Z 25 , Z 26 , Z 27 and Z 28 Each independently represents a single bond, -C≡C-, C1~C 15 Straight chain alkylene, C3~C15 Branched alkylene, C2~C 15 Straight chain alkenylene or C3~C 15 branched alkenylene, wherein the C1 to C 15 Straight chain alkylene, the C3~C 15 The branched alkylene group, the C2 to C 15 Straight chain alkenylene or the C3~C 15 The branched alkenylene group is unsubstituted or at least one hydrogen atom is substituted by a halogen atom, and / or at least one -CH2- is substituted by -SiR e 2-, -S-, -O-, -CO-, -COO-, -OCO-, -CO-NR e -or-NR e -CO-substituted, and the -SiR e 2-, -S-, -O-, -CO-, -COO-, -OCO-, -CO-NR e - and -NR e -CO- are not directly connected to each other, where R e is hydrogen, C1-C4 straight chain alkyl or C3-C4 branched chain alkyl, and is bonded to two R e The groups may be the same as or different from each other;
[0065] Ring B 4 , B 5 , B 6 and B 7 Each is independently an unsubstituted 1,4-phenylene, 1,4-cyclohexylene, benzofuran-2,5-diyl, 1,3-dioxane-2,5-diyl, tetrahydropyran-2,5-diyl, a divalent dioxa-bicyclo[2.2.2]octane functional group, a divalent trioxa-bicyclo[2.2.2]octane functional group, tetrahydronaphthalene-2,6-diyl or indan-2,5-diyl, or a 1,4-phenylene, 1,4-cyclohexylene, benzofuran-2,5-diyl, 1,3-dioxane-2,5-diyl, tetrahydropyran-2,5-diyl, a divalent dioxa-bicyclo[2.2.2]octane functional group, a divalent trioxa-bicyclo[2.2.2]octane functional group, tetrahydronaphthalene-2,6-diyl or indan-2,5-diyl group, or a 1,4-phenylene, 1,4-cyclohexylene, benzofuran-2,5-diyl, 1,3-dioxane-2,5-diyl, tetrahydropyran-2,5-diyl, divalent dioxa-bicyclo[2.2.2]octane functional group, a divalent trioxa-bicyclo[2.2.2]octane functional group, 4-phenylene, 1,4-cyclohexylene, benzofuran-2,5-diyl, 1,3-dioxane-2,5-diyl, tetrahydropyran-2,5-diyl, divalent dioxa-bicyclo[2.2.2]octane functional group, divalent trioxa-bicyclo[2.2.2]octane functional group, tetrahydronaphthalene-2,6-diyl or indane-2,5-diyl, wherein at least one substituent is selected from F, Cl, CN, Cl~C 12 Straight chain alkyl, C3~C 12 Branched alkyl, C2~C 12 Straight chain alkenyl, C2~C 12 Straight chain alkynyl, C4~C 12 Branched alkenyl or C4~C 12 branched alkynyl, wherein the C1 to C12 Straight chain alkyl, the C3~C 12 The branched alkyl group, the C2 to C 12 Straight chain alkenyl, the C2 to C 12 Straight chain alkynyl, the C4~C 12 Branched alkenyl or the C4~C 12 The branched alkynyl group is unsubstituted or at least one hydrogen atom is substituted by a halogen atom, and / or at least one -CH2- is substituted by -O-, -CO-, -COO- or -OCO-, and the -O-, -CO-, -COO- and -OCO- are not directly connected to each other;
[0066] M 1 is a single bond, -CH2O-, -OCH2-, -CH2CH2-, -CH=CH-, -C≡C-, -CH2-, -C(CH3)2-, -C(CF3)2-, -SiH2-, -Si(CH3)2- or -Si(CF3)2-;
[0067] R 23 and R 24 Each independently is C1~C 30 Straight chain alkyl or C3~C 30 branched alkyl, wherein the C1 to C 30 Straight chain alkyl or the C3~C 30 The branched alkyl group is unsubstituted or at least one hydrogen atom is substituted by a halogen atom, and / or at least one -CH2- is substituted by -Si-, -O-, -CO-, -COO- or -OCO-, and the -Si-, -O-, -CO-, -COO- and -OCO- are not directly connected to each other; and
[0068] n 22 and n 23 Each independently represents an integer between 0 and 3, and when n 22 When it is 2 or more, two or more B 4 Group and M 1 The groups are the same or different from each other, and when n 23 When it is 2 or more, two or more B 6 Group and Z 27 The groups are respectively the same as or different from each other.
[0069] Preferably, the compound represented by formula (III) can be further limited to ring B 4 With Ring B 5 Each is independently 1,4-cyclohexylene, 1,4-phenylene, indane-1,5-diyl or indane-2,5-diyl which is unsubstituted or has at least one hydrogen substituted by fluorine or methyl; K 21 and K22 are each independently hydrogen or methyl; Z 23 With Z 24 is a single bond; M 1 is a single bond, -CH2O- or -OCH2-; and n 22 is 1, 2 or 3, when n 22 ≥2, multiple B 4 With B 5 are the same as or different from each other, the plural M 1 They may be the same as or different from each other.
[0070] Specifically, the compounds represented by the above formula (III) can be exemplified as follows, including but not limited to:
[0071]
[0072] The content of other polymerizable compounds that may be included in the liquid crystal composition of the present invention is based on the overall content of the liquid crystal compound as 100%, and the added ratio range is 0.01 to 10% by weight, preferably 0.02 to 2% by weight, and more preferably 0.05 to 1% by weight, but the amount can be adjusted according to actual conditions and is not limited to this.
[0073] The liquid crystal composition of the present invention may further include additives, including but not limited to: chiral dopants, UV stabilizers, antioxidants, free radical scavengers, nanoparticles, etc.
[0074] [Liquid crystal display device]
[0075] The present invention further provides a liquid crystal display device, which comprises any one of the above-mentioned liquid crystal compositions.
[0076] [Preparation Example]
[0077] The preparation process of the polymerizable compound of the present invention is described below by taking the preparation processes of the polymerizable compounds of formula (I-1) and formula (I-6) as examples.
[0078] The synthesis process of the polymerizable compound formula (I-1) (i.e., PPcMA described below) is as follows. The synthesis steps of compounds 1 to 5 and the polymerizable compound formula (I-1) (i.e., PPcMA described below) are described in order below:
[0079]
[0080] 4-Bromophenol (5.02 g, 29 mmol), imidazole (2.37 g, 34.8 mmol) and dichloromethane (50 mL) were placed in a 250 mL double-necked flask and stirred at room temperature until dissolved. Tert-Butyldimethylsilyl chloride (4.35 g, 29 mmol) was added under an ice bath and reacted at room temperature for 2 hours. After the reaction was completed, ethyl acetate and water were used for extraction, and the organic layer was collected after drying with magnesium sulfate. The solvent of the collected organic layer was removed using a rotary concentrator, and then column chromatography was performed to obtain compound 1 as a colorless liquid.
[0081] Compound 1 (8.03 g, 28 mmol) and anhydrous tetrahydrofuran (Anhydrous Tetrahydrofuran, 60 mL) were placed in a 250 mL double-necked flask filled with nitrogen. The temperature was lowered to -78°C, and 2.2 M n-butyllithium solution (n-Butyllithium solution 2.2M in hexane, 13.44 mL) was slowly injected into the double-necked flask with a syringe. The temperature was maintained between -60°C and -80°C for 1 hour, and then triisopropyl borate (Triisopropyl borate, 6.25 mL, 33.6 mmol) was added. The temperature was raised to room temperature and stirred for 1 hour. 1N hydrochloric acid aqueous solution (HCl, 33.6 mL) was added to terminate the reaction, and the mixture was extracted with ethyl acetate and water. The organic layer was collected after drying with magnesium sulfate. The solvent of the collected organic layer was removed using a rotary concentrator, and then column chromatography was performed to obtain compound 2 as a white solid.
[0082] Compound 2 (6.80 g, 27 mmol), 6-Bromo-2-Tetralone (4.05 g, 18 mmol), potassium carbonate (9.32 g, 67.5 mmol), tetrahydrofuran (THF, 100 mL) and water (22.5 mL) were placed in a 250 mL reaction flask and stirred. Nitrogen was added to deoxygenate and stirred vigorously for 1 hour. Tetrakis(triphenyl-phosphine)palladium(0) (0.52 g, 0.45 mmol) was added and refluxed at 70°C for 8 hours. After the reaction was completed, it was extracted with ethyl acetate and water, and the organic layer was collected after drying with magnesium sulfate. The solvent of the collected organic layer was removed using a rotary concentrator, and then column chromatography was performed to obtain compound 3 as a light yellow solid.
[0083] Compound 3 (7.04 g, 20 mmol) and methanol (60 mL) were placed in a 250 mL double-necked flask and stirred until dissolved. Sodium borohydride (30 mmol) was added to the double-necked flask in batches under an ice bath and stirred at room temperature for 1 hour. After the reaction was completed, ethyl acetate and water were used for extraction, and the organic layer was collected after drying with magnesium sulfate. The solvent of the collected organic layer was removed using a rotary concentrator, and then column chromatography was performed to obtain compound 4 as a brown liquid.
[0084] Compound 4 (7.08 g, 20 mmol) and tetrahydrofuran (50 mL) were placed in a 250 mL reaction flask, dissolved and cooled to 0°C. 1 M tetrabutylammonium fluoride solution (26 ml, 26 mmol) was slowly added, and the mixture was returned to room temperature and stirred for 2 hours. After the reaction was completed, the mixture was extracted with ethyl acetate and water, and dried with magnesium sulfate, and the organic layer was collected. The solvent of the collected organic layer was removed using a rotary concentrator, and then column chromatography was performed to obtain compound 5 as a yellow solid.
[0085] Compound 5 (3.60 g, 15 mmol), methacrylic acid (Methacrylic acid, 0.77 g, 9 mmol), 4-dimethylaminopyridine (4-Dimethylaminopyridine, 1.10 g, 9 mmol) and tetrahydrofuran (tetrahydrofuran, 50 mL) were placed in a 250 mL reaction bottle and stirred to dissolve. The reaction was cooled to 0°C, and N,N'-dicyclohexylcarbodiimide (12.38 g, 60 mmol) was slowly added dropwise to tetrahydrofuran (20 mL), stirred at 0°C for 30 minutes, returned to room temperature and stirred for 8 hours. After the reaction was completed, the white precipitate was filtered by vacuum, extracted with ethyl acetate and water, dried with magnesium sulfate, and the organic layer was collected. The solvent of the collected organic layer was removed using a rotary concentrator, and then column chromatography was performed to obtain the white solid compound PPcMA.
[0086] The polymerizable compound PPcMA was analyzed by nuclear magnetic resonance spectroscopy, and the spectral information obtained was as follows: 1 H NMR (CDCl3, 400MHz): 1.94 (s, 1H), 2.08 (s, 1H), 1.98-2.16 (m, 2H), 2.89-3.22 (m, 4H), 5.28-5.34 (m, 1H), 5.55 (t, J = 1.6Hz, 1H), 5.77 (t,J=1.6Hz,1H),6.09(s,1H),6.37(s,1H),7.14(d,J=3.8Hz,1H),7.14-7.18(m,2H),7.32(s,1H),7.35(q,J=3Hz,1H),7.58(m,2H).
[0087] The synthesis process of the polymerizable compound formula (I-6) (i.e., PPcO1PPMA described later) is as follows. The synthesis steps of compounds 6 to 8 and the polymerizable compound formula (I-6) (i.e., PPcO1PPMA described later) are described in sequence below:
[0088]
[0089] 6-Bromo-2-Tetralone (4 g, 22 mmol), methanol (100 mL) and tetrahydrofuran (30 mL) were placed in a 250 mL double-necked flask and stirred until dissolved. Sodium borohydride was added to the double-necked flask in batches under an ice bath and stirred at room temperature for 1 hour. After the reaction was completed, it was extracted with ethyl acetate and water, and dried with magnesium sulfate, and the organic layer was collected. The solvent of the collected organic layer was removed using a rotary concentrator, and then column chromatography was performed to obtain compound 7 as a brown liquid.
[0090] Compound 7 (4.54 g, 20 mmol) and tetrahydrofuran (60 mL) were placed in a 250 mL double-necked bottle and stirred until dissolved. 60% sodium hydride (60% NaH, 4 g, 100 mmol) was added under an ice bath and stirred for 1 hour under an ice bath. 4-Bromobenzyl bromide (6.00 g, 24 mmol) was added and dissolved in tetrahydrofuran (20 mL) and stirred at room temperature for 8 hours. The reaction solution was poured into ice cubes to terminate the reaction. After the reaction was completed, it was extracted with ethyl acetate and water. After drying with magnesium sulfate, the organic layer was collected. The solvent of the collected organic layer was removed using a rotary concentrator, and then column chromatography was performed to obtain compound 8 as a brown solid.
[0091] Compound 8 (7.09 g, 18 mmol), 4-hydroxyphenylboronic acid (12.42 g, 90 mmol), potassium carbonate (7.45 g, 54 mmol), tetrahydrofuran (150 mL) and water (30 mL) were placed in a 500 mL reaction flask and stirred. Nitrogen was added to deoxygenate and stirred vigorously for 1 hour. Tetrakis(triphenyl-phosphine)palladium(0) (0.751 g, 0.65 mmol) was added and refluxed at 70°C for 8 hours. After the reaction was completed, it was extracted with ethyl acetate and water, dried with magnesium sulfate, and the organic layer was collected. The solvent of the collected organic layer was removed using a rotary concentrator, and then column chromatography was performed to obtain compound 9 as a light yellow solid.
[0092] Compound 9 (5.32 g, 12.6 mmol), methacrylic acid (6.50 g, 75.6 mmol), 4-dimethylaminopyridine (0.77 g, 6.3 mmol) and dichloromethane (100 mL) were placed in a 250 mL reaction bottle. The reaction temperature was lowered to 0°C, and N,N'-dicyclohexylcarbodiimide (6.50 g, 31.5 mmol) dissolved in dichloromethane (20 mL) was slowly added dropwise, stirred at 0°C for 30 minutes, returned to room temperature and stirred for 3 hours. After the reaction was completed, the white precipitate was filtered by vacuum, extracted with ethyl acetate and water, dried with magnesium sulfate, and the organic layer was collected. The solvent of the collected organic layer was removed using a rotary concentrator, and then column chromatography was performed to obtain a white solid polymerizable compound PPcO1PPMA.
[0093] The liquid crystal compound PPcO 1PPMA was analyzed by nuclear magnetic resonance spectroscopy, and the spectral information obtained is as follows: 1 H NMR (CDCl3, 400MHz): 1.91-2.00 (m, 1H), 2.08 (d, J = 0.4Hz, 6H), 2.13-2.16 (m, 1H), 2.82-3.17 (m, 4H), 3.90-3.96 (m, 1H), 4.70 ( q,J=2Hz,2H),5.77(q,J=6.4Hz,2H),6.37(s,2H),7.15-7.20(m,2H),7.30-7.34(m,2H),7.45(d,J=4Hz,2H),7.54-7.61(m,6H).
[0094] The liquid crystal structures used in the preparation examples and embodiments of this specification are represented by the codes in Table 1:
[0095] Table 1:
[0096]
[0097] For example: is 3CPO2, It is 1.3PPcMA.
[0098] The following examples were tested using the following methods:
[0099] Dielectric anisotropy (Δε): The liquid crystal composition is placed in a liquid crystal box, and a voltage of 0V to 30V is applied to the liquid crystal box at a temperature of 25°C. The average dielectric constant measured in the direction parallel to the long axis of the liquid crystal molecules is ε‖ , the average dielectric constant measured perpendicular to the long axis of the liquid crystal molecules is ε ⊥ , dielectric anisotropy (Δε) = ε ‖ -ε ⊥ .
[0100] Refractive index anisotropy (Δn): The liquid crystal composition (or test liquid) is measured using an Abbe refractometer (manufacturer: ATAGO; model: DR-M2) with a polarizing plate installed on the eyepiece. First, wipe the main prism surface of the Abbe refractometer in a single direction, then drop a small amount of liquid crystal composition (or test liquid) on the main prism, and then measure the refractive index anisotropy at a test temperature of 25°C using a filter with a wavelength of 589nm. When the polarization direction is parallel to the wiping direction, the measured refractive index is n. ‖ ; When the polarization direction is perpendicular to the wiping direction, the measured refractive index is n ⊥ ; Refractive index anisotropy (Δn) = n ‖ -n ⊥ .
[0101] Clearing point temperature (Tni): Using a differential scanning calorimeter (DSC) system, place 0.5 to 10 mg of the liquid crystal composition on an aluminum plate, and determine the phase change temperature by the starting point of the endothermic peak and the exothermic peak due to the phase change of the liquid crystal composition. The phase change is represented by: the crystalline phase is marked as C, the smectic phase is marked as S, the nematic phase is marked as N, and the liquid is marked as I. Among them, the phase change temperature from the nematic phase to the liquid is the clearing point temperature (Tni).
[0102] Low temperature stability (LTS): 0.5 g of the liquid crystal composition was placed in a 7 ml sample bottle in a -20°C freezer. The crystal precipitation was observed every day, and the number of days without the generation of solid precipitates was recorded as the number of days of LTS.
[0103] Polymer stabilized alignment process time: Prepare a liquid crystal composition as a mother liquid. Add a corresponding weight of polymerizable compound to the liquid crystal mother liquid as 100 parts by weight, and perform vacuum infusion into the test box. Then perform the polymer stabilized alignment (PSA) process step to polymerize the polymerizable compound. The conditions of the above PSA process step are to apply a voltage of 12V to the test piece and place it under a UV lamp (0.1mW / cm 2 ) and confirm that the Ton of the test box falls within 10ms. The required time is the process time.
[0104] Polymer stabilization alignment UV process: After the above polymer stabilization alignment process is completed, the test box is placed under a UV lamp at 0.5mW / cm 2 Irradiate for 120 minutes.
[0105] Pretilt Angle Stability: The test box after the polymer stable alignment UV process was placed in a high temperature 60°C oven, and 20V 60Hz AC was applied for 72 hours to compare the difference in pretilt angle of the test box before and after the electric field.
[0106] [Example]
[0107] The mother liquor composition of LC-1 is shown in Table 2 below:
[0108] Table 2: LC-1 mother liquor composition:
[0109] LC-1 wt% 3CC2 24.5 3CC5 4.25 3CPO2 2.75 3CCP1 3.5 3CPP2 9 3CP2YO2 7 2CPYO2 4.25 3CPYO2 11 3C1OYO1 3.75 3C1OYO2 3.75 3CYO2 17.25 3CCYO2 9 T 73.87 Δε -3.02 Δn 0.0962 LTS(-20℃) 24D
[0110] The polymerizable compound of the present invention is added to LC-1 to form the liquid crystal composition of the present invention.
[0111] Table 3: Example 1 & Comparative Examples 1 to 3:
[0112] Example 1 Comparative Example 1 Comparative Example 2 Comparative Example 3 LC-1(%) 100 100 100 100 PPcMA(%) 0.3 - - - PRIMA(%) - 0.3 - - PNMA(%) - - 0.3 - 1.3PPcMA(%) - - - 0.3 Process time(s) 205 210 110 210 Initial PTA(°) 89.91 89.9 89.9 89.92 PTA after stress (°) 89.85 89.55 89.81 89.71 ΔPTA(°) 0.06 0.35 0.09 0.21 LTS(-20℃) 19D 15D 8D 12D
[0113] Table 4: Example 2 & Comparative Example 4:
[0114] Example 2 Comparative Example 4 LC-1(%) 100 100 PPPcMA(%) 0.3 - PGRIMA(%) - 0.3 Process time(s) 60 70 Initial PTA(°) 89.89 89.91 PTA after stress (°) 89.74 88.97 ΔPTA(°) 0.15 0.94 LTS(-20℃) 9D 10D
[0115] Table 5: Examples 3 to 6:
[0116] Example 3 Example 4 Example 5 Example 6 LC-1(%) 100 100 100 100 PPcMA(%) - - - 0.3 PPcO1PPMA(%) 0.2 0.15 0.15 - PPcO1G'PMA (%) - - 0.15 - PG1OGPMA(%) - 0.15 - 0.25 Process time(s) 160 180 190 180 Initial PTA(°) 89.89 89.92 89.9 89.88 PTA after stress (°) 89.82 89.85 89.84 89.86 ΔPTA(°) 0.07 0.07 0.06 0.02 LTS(-20℃) 12D 12D 10D 8D
[0117] As shown in Table 3, in the liquid crystal composition, among the polymerizable compounds having two rings, PPcMA, PRIMA, PNMA and 1.3PPcMA have the best pretilt angle stability and low-temperature storage stability; as shown in Table 4, among the polymerizable compounds having three rings, PPPcMA also has better pretilt angle stability than PGRIMA; as shown in Table 5, PPcO 1PPMA having a four-ring structure also has excellent pretilt angle stability and low-temperature storage stability, and the liquid crystal composition comprising the polymerizable compound of the present invention and other polymerizable compounds at the same time can also achieve better pretilt angle stability and low-temperature storage stability.
[0118] [Application fields]
[0119] The polymerizable compound and liquid crystal composition of the present invention can be applied to any type of liquid crystal display devices such as VA, TN, IPS, FFS, OCB and PDLC, as well as the application of smart glass.
[0120] The above are only preferred implementations of the present disclosure. It should be pointed out that a person skilled in the art can make several improvements and modifications without departing from the principles of the present disclosure, and these improvements and modifications should also be regarded as within the protection scope of the present disclosure.
Claims
1. A polymerizable compound, characterized in that It has the chemical formula shown in formula (I): in Ring A and Ring B are each independently 1,4-phenylene which is unsubstituted or has at least one hydrogen on carbon substituted with fluorine, C1-C5 straight-chain alkylene or C3-C5 branched-chain alkylene, wherein the alkylene is unsubstituted or has at least one -CH2- substituted with -O- or -C=C-; Z1 and Z2 are each independently a C1-C4 straight chain alkylene, -CF2O-, -OCF2- or a single bond, wherein the alkylene is unsubstituted or at least one -CH2- is substituted by -O-, -C=C- or -C≡C-; n and m are each 0, 1, 2, 3 or 4, and n+m=1-4; when n+m≥2, the plurality of rings A and B are the same as or different from each other, and Z1 and Z2 are the same as or different from each other; R is C1~C 12 Alkyl, C1~C 12 Alkoxy, C2~C 12 alkenyl or P, wherein the alkenyl is unsubstituted or has at least one carbon hydrogen substituted with fluorine; and P is 2. The polymerizable compound according to claim 1, characterized in that wherein Z1 and Z2 are each independently -OCH2-, -CH2O-, -O(CH2)3-, -(CH2)3O-, -OC2H4O-, -C=C-, -C≡C-, -CF2O-, -OCF2- or a single bond.
3. The polymerizable compound according to claim 1, characterized in that Wherein Z1 and Z2 are each independently -OCH2-, -CH2O- or a single bond; n+m=1-3.
4. The polymerizable compound according to claim 1, characterized in that Wherein Z1 is a single bond, n=1-2, m=0, R is P, and the definition of P is the same as that in claim 1.
5. The polymerizable compound according to claim 1, wherein Wherein Z1 and Z2 are each independently -OCH2-, -CH2O- or a single bond, n=0 to 3, m=0 to 3, n+m=3, R is P, and the definition of P is the same as that in claim 1.
6. A liquid crystal composition, characterized in that: The liquid crystal composition comprises one or more polymerizable compounds as claimed in claim 1 .
7. The liquid crystal composition according to claim 6, wherein The liquid crystal composition further comprises one or more compounds of formula (II): in R 21 and R 22 are independently hydrogen, a halogen atom, a C1-C 15 Alkyl or C2~C 15 alkenyl, and wherein the C1 to C 15 Alkyl or the C2~C 15 The alkenyl group is unsubstituted or at least one hydrogen atom is substituted by a halogen atom, and / or at least one -CH2- is substituted by -O-, and -O- is not directly connected to -O-; B 1 , B 2 and B 3 are each independently 1,4-phenylene, 1,4-cyclohexylene, 2,5-benzofuranylene, 1,3-dioxane-2,5-diyl, 2,5-tetrahydropyranylene, a divalent dioxa-bicyclo[2.2.2]octane functional group, a divalent trioxa-bicyclo[2.2.2]octane functional group, tetralin-2,6-diyl or indan-2,5-diyl, wherein the 1,4-phenylene, the 1,4-cyclohexylene, , the 1,3-dioxane-2,5-diyl, the 2,5-benzofuranyl, the tetralin-2,6-diyl, the indan-2,5-diyl or the 2,5-tetrahydropyranyl is unsubstituted or at least one hydrogen atom is substituted by a halogen atom or -CN, and / or at least one -CH2- is substituted by -O-, -N- or -S-, and the -O-, -N- and -S- substitution atoms are not directly connected to each other; Z 21 and Z 22 Each independently represents a single bond, C1-C4 alkylene, C2-C4 alkenylene, or C2-C4 alkynylene, wherein the C1-C4 alkylene, the C2-C4 alkenylene, or the C2-C4 alkynylene is unsubstituted or at least one hydrogen atom is substituted by a halogen atom or -CN, and / or at least one -CH2- is substituted by -O- or -S-, and -O- is not directly connected to -O- or -S-, and -S- is not directly connected to -S-; and n 21 is 0, 1, or 2, and when n 21 When the two B 1 The groups are the same as or different from each other.
8. The liquid crystal composition according to claim 6, wherein: The liquid crystal composition further comprises one or more compounds of formula (II-1) or formula (II-2): in R 21 and R 22 are independently hydrogen, a halogen atom, a C1-C 15 Alkyl or C2~C 15 alkenyl, and wherein the C1 to C 15 Alkyl or the C2~C 15 The alkenyl group is unsubstituted or at least one hydrogen atom is substituted by a halogen atom, and / or at least one -CH2- is substituted by -O-, and -O- is not directly connected to -O-; B 1 and B 2 are each independently 1,4-phenylene, 1,4-cyclohexylene, 2,5-benzofuranylene, 1,3-dioxane-2,5-diyl, 2,5-tetrahydropyranylene, a divalent dioxa-bicyclo[2.2.2]octane functional group, a divalent trioxa-bicyclo[2.2.2]octane functional group, tetralin-2,6-diyl or indan-2,5-diyl, wherein the 1,4-phenylene, the 1,4-cyclohexylene, , the 1,3-dioxane-2,5-diyl, the 2,5-benzofuranyl, the tetralin-2,6-diyl, the indan-2,5-diyl or the 2,5-tetrahydropyranyl is unsubstituted or at least one hydrogen atom is substituted by a halogen atom or -CN, and / or at least one -CH2- is substituted by -O-, -N- or -S-, and the -O-, -N- and -S- substitution atoms are not directly connected to each other; Z 22 are independently a single bond, C1-C4 alkylene, C2-C4 alkenylene, or C2-C4 alkynylene, wherein the C1-C4 alkylene, the C2-C4 alkenylene, or the C2-C4 alkynylene is unsubstituted or at least one hydrogen atom is substituted by a halogen atom or -CN, and / or at least one -CH2- is substituted by -O- or -S-, and -O- is not directly connected to -O- or -S-, and -S- is not directly connected to -S-; and n 21 is 0, 1, or 2, and when n 21 When the two B 1 The groups are the same as or different from each other.
9. The liquid crystal composition according to any one of claims 6 to 8, wherein The liquid crystal composition further comprises one or more compounds represented by formula (III), formula (IV) or formula (V): in K 21 , K 22 , K 23 and K 24 are each independently hydrogen or methyl; Z 23 and Z 24 Each independently is a single bond, C1~C 15 Straight chain alkylene, C3~C 15 Branched alkylene, C2~C 15 Straight chain alkenylene or C3~C 15 branched alkenylene, wherein the C1 to C 15 Straight chain alkylene, the C3~C 15 The branched alkylene group, the C2 to C 15 Straight chain alkenylene or the C3~C 15 The branched alkenylene group is unsubstituted or at least one hydrogen atom is substituted by a halogen atom, and / or at least one -CH2- is substituted by -O-, -CO-, -COO- or -OCO-, and the -O-, -CO-, -COO- and -OCO- are not directly connected to each other; Z 25 , Z 26 , Z 27 and Z 28 Each independently represents a single bond, -C≡C-, C1~C 15 Straight chain alkylene, C3~C 15 Branched alkylene, C2~C 15 Straight chain alkenylene or C3~C 15 branched alkenylene, wherein the C1 to C 15 Straight chain alkylene, the C3~C 15 The branched alkylene group, the C2 to C 15 Straight chain alkenylene or the C3~C 15 The branched alkenylene group is unsubstituted or at least one hydrogen atom is substituted by a halogen atom, and / or at least one -CH2- is substituted by -SiR e 2-, -S-, -O-, -CO-, -COO-, -OCO-, -CO-NR e -or-NR e -CO-substituted, and the -SiR e 2-, -S-, -O-, -CO-, -COO-, -OCO-, -CO-NR e - and -NR e -CO- are not directly connected to each other, where R e is hydrogen, C1-C4 straight chain alkyl or C3-C4 branched chain alkyl, and is bonded to two R e The groups are the same as or different from each other; B 4 , B 5 , B 6 and B 7 Each is independently an unsubstituted 1,4-phenylene, 1,4-cyclohexylene, benzofuran-2,5-diyl, 1,3-dioxane-2,5-diyl, tetrahydropyran-2,5-diyl, a divalent dioxa-bicyclo[2.2.2]octane functional group, a divalent trioxa-bicyclo[2.2.2]octane functional group, tetrahydronaphthalene-2,6-diyl or indan-2,5-diyl, or a 1,4-phenylene, 1,4-cyclohexylene, benzofuran-2,5-diyl, 1,3-dioxane-2,5-diyl, tetrahydropyran-2,5-diyl, a divalent dioxa-bicyclo[2.2.2]octane functional group, a divalent trioxa-bicyclo[2.2.2]octane functional group, tetrahydronaphthalene-2,6-diyl or indan-2,5-diyl group, or a 1,4-phenylene, 1,4-cyclohexylene, benzofuran-2,5-diyl, 1,3-dioxane-2,5-diyl, tetrahydropyran-2,5-diyl, divalent dioxa-bicyclo[2.2.2]octane functional group, a divalent trioxa-bicyclo[2.2.2]octane functional group, 4-phenylene, 1,4-cyclohexylene, benzofuran-2,5-diyl, 1,3-dioxane-2,5-diyl, tetrahydropyran-2,5-diyl, divalent dioxa-bicyclo[2.2.2]octane functional group, divalent trioxa-bicyclo[2.2.2]octane functional group, tetrahydronaphthalene-2,6-diyl or indane-2,5-diyl, wherein at least one substituent is selected from F, Cl, CN, Cl~C 12 Straight chain alkyl, C3~C 12 Branched alkyl, C2~C 12 Straight chain alkenyl, C2~C 12 Straight chain alkynyl, C4~C 12 Branched alkenyl or C4~C 12 A branched alkynyl group, wherein the C1 to C 12 Straight chain alkyl, the C3~C 12 The branched alkyl group, the C2 to C 12 Straight chain alkenyl, the C2 to C 12 Straight chain alkynyl, the C4~C 12 Branched alkenyl or the C4~C 12 The branched alkynyl group is unsubstituted or at least one hydrogen atom is substituted by a halogen atom, and / or at least one -CH2- is substituted by -O-, -C O-, -CO O- or -OC O-, and the -O-, -C O-, -CO O- and -OC O- are not directly connected to each other; M 1 is a single bond, -CH2O-, -OCH2-, -CH2CH2-, -CH=CH-, -C≡C-, -CH2-, -C(CH3)2-, -C(CF3)2-, -SiH2-, -Si(CH3)2- or -Si(CF3)2-; R 23 and R 24 Each independently is C1~C 30 Straight chain alkyl or C3~C 30 branched alkyl, wherein the C1 to C 30 Straight chain alkyl or the C3~C 30 The branched alkyl group is unsubstituted or at least one hydrogen atom is substituted by a halogen atom, and / or at least one -CH2- is substituted by -Si-, -O-, -CO-, -CO O- or -OCO-, and the -Si-, -O-, -CO-, -CO O- and -OCO- are not directly connected to each other; and n 22 and n 23 Each independently represents an integer between 0 and 3, and when n 22 When the number is 2 or more, the two or more B 4 Group and M 1 The groups are the same or different from each other, and when n 23 When the number is 2 or more, the two or more B 6 Group and Z 27 The groups are respectively the same as or different from each other.
10. The liquid crystal composition according to claim 9, wherein The compound represented by formula (III) is further defined as: B 4 With B 5 Each is independently 1,4-cyclohexylene, 1,4-phenylene, indane-1,5-diyl or indane-2,5-diyl which is unsubstituted or has at least one hydrogen substituted by fluorine or methyl; K 21 and K 22 are each independently hydrogen or methyl; Z 23 With Z 24 is a single bond; M 1 is a single bond, -CH2O- or -OCH2-; and n 22 is 1, 2 or 3, when n 22 ≥2, multiple B 4 With B 5 are the same as or different from each other, the plural M 1 be the same as each other or different from each other.
11. A liquid crystal display device, characterized in that: The liquid crystal display device comprises a liquid crystal composition as claimed in any one of claims 6 to 8.
